CLINICAL_TRIALS
trial_result
· 2019-10-11
Clinical Trial Update: Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer [Phase 2]
Summary
Phase 2 trial update evaluating cetuximab standard versus dose-escalation in first-line colorectal cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-10-11